YUMAB GmbH
  • Xing
  • Linkedin
  • Mail
  • Home
  • YU10
    • Anniversary Event
    • Milestones
    • YUMAB in numbers
    • Behind the Scenes
    • Guestbook
    • Newsletter
  • Company
    • Team
    • Network & Partners
    • Career
  • Contract Research
    • Discovery & Development of Antibodies from Target to Lead
      • Hit Discovery
      • Lead Engineering
      • Lead Development
    • Antibody Engineering
    • Antibody Humanization
    • Libraries
  • Partnering & Pipeline
    • Partnering, Collaboration & Pipeline
    • Project design & Licensing
  • Platform & Technologies
    • Library technologies
    • Antibody Discovery
    • Bioinformatics / YUcare
    • Antibody Engineering
    • Antibody Humanization
  • News & Events
    • News
    • Events
  • Contact
    • Contact
    • Directions
  • Search
  • Menu

Behind the Scenes

PreviousNext
YUMAB celebrates 10th anniversary - Read more
Ymmunobio signs collaboration agreement with YUMAB - Read more
First hospitalized COVID-19 patient treated with COR-101 antibody - Read more
Human SARS-CoV-2 antibody COR-101 shows high efficacy in animal model - Read more
CORAT Therapeutics GmbH Mechanism of action for human SARS-CoV-2 antibody COR-101 identified - Read more
Innovation Award for CORAT’s COVID-19 antibody development - Read more
COVID-19: Media coverage of YUMAB’s activities - Read more
CORAT’s human COVID-19 antibody ready for clinical trials - Read more

YUMAB GmbH

Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany

Phone Yumab Phone: +49 531 481170-0
Fax Yumab Fax: +49-531 481170-17

Newsletter

Want to know what we’re up to? Sign up for the newsletter here.

Newsletter Registration

More Information

Legal notice
Disclaimer, Data Privacy Statement
Terms and conditions
Sitemap

Scroll to top